Universitaetsspital Bern, Inselspital

Bern 43017-3521

1 studies enrolling now · 7 studies all time

What they study most

Advanced or Metastatic Solid Tumors, Multiple Myeloma, Narcolepsy Type 1, Narcolepsy Type 2, Nonalcoholic Steatohepatitis, Relapsing-remitting Multiple Sclerosis (RRMS), Thyroid Eye Disease

Studies at this site

• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• Comparison Between ABP 692 and Ocrevus® (Ocrelizumab) — Running, not enrolling
• A Study of Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Ciltacabtagene Autoleucel Versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) Followed by Autologous Stem Cell Transplant (ASCT) in Participants With Newly Diagnosed Multiple Myeloma — Running, not enrolling
• A Study of Efgartigimod PH20 SC Given by Prefilled Syringe in Adults With Thyroid Eye Disease. — Stopped early
• A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• AURORA: A Study for the Efficacy and Safety of Cenicriviroc (CVC) for the Treatment of Liver Fibrosis in Adults With Nonalcoholic Steatohepatitis (NASH) — Stopped early